3-methylglutaconic aciduria (3-MGA) type II, more commonly referred to as Barth syndrome (BTHS), is a systemic OA caused by mutations in the TAZ gene that codes for tafazzin (previously known as G4.5). The gene discussed is TAFAZZIN; the disease is 3-methylglutaconic aciduria.